May 22, 2026 a 09:00 pm

BDX: Analysts Ratings - Becton, Dickinson and Company

Becton, Dickinson and Company Stock Overview

Becton, Dickinson and Company (BDX) has demonstrated relative stability in the healthcare sector with a broad range of medical devices and diagnostic products. Recent analysts' ratings indicate a cautious but mostly positive outlook. The company's core segments support defensive investments, ideal for portfolios seeking stability amid market uncertainty.

Historical Stock Grades

Recommendation Count Score
Strong Buy 1
Buy 6
Hold 9
Sell 0
Strong Sell 0
Analyst Ratings History Becton, Dickinson and Company Stock Chart

Sentiment Development

The sentiment around BDX has shown a shift toward more cautious stances over recent months. A decrease in "Strong Buy" recommendations reflects a growing market caution. Notably, "Hold" ratings have overtaken as analysts reassess market conditions.

  • The total number of recommendations showed slight variation with minor drops in "Strong Buy" ratings.
  • ”Buy” ratings remained stable, while “Hold” ratings showed a consistent increase, indicating hesitation.
  • No significant movements were observed in "Sell" or "Strong Sell" categories, inferring steady confidence.

Percentage Trends

The percentage of "Strong Buy" ratings decreased, with analysts gravitating towards neutral positions. The dominance of "Hold" suggests a repositioning towards caution, potentially anticipating more market volatility.

  • From May 2025 to May 2026, "Strong Buy" ratings dropped from 23% to 5% of total ratings.
  • "Buy" ratings saw a slight decline from 36% to 30% in the same period, while "Hold" ratings increased significantly from 41% to 65%.
  • The shift reveals reduced enthusiasm, likely tied to broader market uncertainties.

Over the past year, "Strong Buy" ratings have significantly decreased, reflecting apprehension likely due to macroeconomic factors.

Latest Analyst Recommendations

Recent analyst recommendations highlight consistent views without significant changes in outlook. Most ratings have been maintained, illustrating steady market perception.

Date New Recommendation Last Recommendation Publisher
2026-05-11 Overweight Overweight Barclays
2026-05-08 Equal Weight Equal Weight Wells Fargo
2026-05-04 Hold Hold TD Cowen
2026-04-17 Neutral Neutral Piper Sandler
2026-03-26 Neutral Neutral Piper Sandler

Analyst Recommendations with Change of Opinion

There have been noteworthy adjustments in opinions over the past year, indicating a nuanced reevaluation of BDX's prospects. The movement from "Buy" to "Neutral" signals a re-assessment of growth projections.

Date New Recommendation Last Recommendation Publisher
2025-05-22 Neutral Buy Citigroup
2025-05-02 Neutral Overweight Piper Sandler
2025-05-01 Market Perform Outperform William Blair
2024-10-01 Buy Neutral Citigroup
2023-07-24 Outperform Market Perform Raymond James

Interpretation

The data implies that while BDX continues to benefit from positive sentiment, there are emerging signs of caution among analysts. The consistency in recommendations, primarily leaning towards "Hold", hints at an anticipation of market stagnation or slight declines. The lack of substantial downgrades to "Sell" or "Strong Sell" indicates that while confidence may be waning, pessimism isn't prevalent. Stability exists, but so does cautious optimism, signaling an environment of uncertainty with potential upside if conditions stabilize.

Conclusion

Becton, Dickinson and Company's analyst ratings reflect a balance between stability and cautious repositioning in response to broader market conditions. The shift from aggressive to neutral stances highlights market dynamics impacting BDX's perceived growth potential. Analysts remain steady with "Hold" recommendations, representing both a trust in BDX's consistent performance and apprehension regarding future growth. Overall, BDX stands as a potential safe harbor with room for positive revaluation, contingent on economic recoveries and stability in healthcare demands.

Smart Data Insight

Master the Perfect Entry & Exit for this Stock

Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.

  • ✅ Identify the "Golden Buying Window"
  • ✅ Avoid high-risk correction cycles
  • ✅ Backtested data from the last 20+ years

Ready to trade with an edge?

Analyze Patterns Now →

Limited Free Lookups Available Today